CORC

浏览/检索结果: 共3条,第1-3条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study 期刊论文
2019, 卷号: 257, 期号: 3, 页码: 529-541
作者:  Li, Xiaoxin;  Dai, Hong;  Li, Xiaorong;  Han, Mei;  Li, Jun
收藏  |  浏览/下载:166/0  |  提交时间:2020/01/03
Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. 期刊论文
Ophthalmology, 2014, 卷号: 121, 期号: 9, 页码: 1740-1747
作者:  Li, Xiaoxin*;  Xu, Gezhi;  Wang, Yusheng;  Xu, Xun;  Liu, Xiaoling
收藏  |  浏览/下载:20/0  |  提交时间:2019/12/03
AE  AMD  AURORA  Abbreviations and Acronyms  Assess the safety and efficacy of KH902 in patients with sUbfoveal choroidal neovasculaRization secOndary to age-Related mAcular degeneration  BCVA  CLEAR-IT  CLinical Evaluation of Anti-angiogenesis in the Retina Intravitreal Trial  CNV  CRT  EXCITE  Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Agerelated Macular Degeneration (AMD)  FA  FP  ICGA  OCT  PRN  Q1M  SAE  VEGF  adverse event  age-related macular degeneration  best-corrected visual acuity  central retinal thickness  choroidal neovascularization  fluorescein angiography  fundus photography  indocyanine green angiography  monthly  optical coherence tomography  pro re nata  severe adverse event  vascular endothelial growth factor  
Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 Study: AURORA study 期刊论文
Ophthalmology, 2014, 卷号: Vol.121 No.9, 页码: 1740-1747
作者:  Li, X.;  Xu, G.;  Wang, Y.;  Xu, X.;  Liu, X.
收藏  |  浏览/下载:14/0  |  提交时间:2019/02/25
Abbreviations  and  Acronyms  adverse  event  AE  age-related  macular  degeneration  AMD  Assess  the  safety  and  efficacy  of  KH902  in  patients  with  sUbfoveal  choroidal  neovasculaRization  secOndary  to  age-Related  mAcular  degeneration  AURORA  BCVA  best-corrected  visual  acuity  central  retinal  thickness  choroidal  neovascularization  CLEAR-IT  CLinical  Evaluation  of  Anti-angiogenesis  in  the  Retina  Intravitreal  Trial  CNV  CRT  Efficacy  and  Safety  of  Ranibizumab  in  Patients  With  Subfoveal  Choroidal  Neovascularization  (CNV)  Secondary  to  Agerelated  Macular  Degeneration  (AMD)  EXCITE  FA  fluorescein  angiography  FP  fundus  photography  ICGA  indocyanine  green  angiography  monthly  OCT  optical  coherence  tomography  PRN  pro  re  nata  Q1M  SAE  severe  adverse  event  vascular  endothelial  growth  factor  VEGF  


©版权所有 ©2017 CSpace - Powered by CSpace